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Abstract
Background: Some patients develop severe and persistent mental illness (SPMI) which is therapy-refractory. The
needs of these patients sometimes remain unmet by therapeutic interventions and they are at high risk of
receiving care that is inconsistent with their life goals. Scholarly discourse has recently begun to address the
suitability of palliative care approaches targeting at enhancing quality of life for these patients, but remains to be
developed.
Method: A cross-sectional survey asked 1311 German-speaking psychiatrists in Switzerland (the total number of
German-speaking members of the Swiss Society for Psychiatry and Psychotherapy) about the care of SPMI patients
in general, and about palliative care approaches in particular. 457 (34.9%) returned the completed survey. In
addition, participants were asked to evaluate three case vignettes of patients with SPMI.
Results: The reduction of suffering and maintaining daily life functioning of the patient were rated as considerably
more important in the treatment of SPMI than impeding suicide and curing the underlying illness. There was broad
agreement that SPMI can be terminal (93.7%), and that curative approaches may sometimes be futile (e.g. 72.4% for
the anorexia nervosa case vignette). Furthermore, more than 75% of the participating psychiatrists were in favour of
palliative care approaches for SPMI.
Conclusions: The results of the present study suggest that the participating psychiatrists in Switzerland regard certain
forms of SPMI as posing high risk of death. Additionally, a majority of respondents consider palliative care approaches
appropriate for this vulnerable group of patients. However, the generalizability of the results to all psychiatrists in
Switzerland or other mental health professionals involved in the care of SPMI is limited. This limitation is important
considering the reservations towards palliative care in the context of psychiatric illness, mainly because of the association
with death and futility. Palliative care approaches, however, are applicable in conjunction with other therapies intended
to prolong life. A next step could be to involve service users and develop a consensus of what palliative care might
encompass in SPMI. A framework for identifying which patients might benefit from palliative care, should be explored for
the future development of care for SPMI patients.
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Background
According to the World Health Organization [1],
‘[p]alliative care is an approach that improves the qual-
ity of life of patients and their families facing the prob-
lem associated with life-threatening illness, through the
prevention and relief of suffering by means of early
identification and impeccable assessment and treatment
of pain and other problems, physical, psychosocial and
spiritual […]’. Based on this broad definition, some psy-
chiatric interventions may be considered palliative, as
they aim primarily to enhance quality of life by means
of adequate symptom control and by focusing on dis-
ability rather than on curing the illness [2]. However,
palliative care as a deliberate approach has not been
widely implemented in mental healthcare, and its tools
have not been deployed in psychiatric practice. Its rele-
vance in the treatment of certain severe and persistent
mental illness (SPMI) such as severe and persistent de-
pression, schizophrenia and anorexia nervosa [2–6] has
only recently been suggested. Studies have consistently
shown higher mortality among patients with SPMI [7,
8], who die 10 to 20 years earlier on average than per-
sons in the general population [9, 10]. At the same
time, a large body of research has focused on ultra-high
risk and prodromal paradigms, representing a clear em-
phasis on early interventions perhaps at the cost of the
development of adequate psychosocial care for patients
in later stages of the disease [11, 12]. Although full re-
mission or recovery is the primary goal of acute psychi-
atric treatment, a substantial number of patients
diagnosed with a major depressive disorder are resistant
to evidence-based treatments, including treatments for
chronic depression such as electro-convulsive therapy
[13] or ketamine infusion [14], and remission rates de-
crease with each additional treatment trial [15]. In cases
of schizophrenia, about one fifth of all patients show
little or no therapeutic response and exhibit increased
susceptibility to several life-threatening comorbidities
[16]. For these patients, evidence-based illness-modify-
ing approaches are unavailable or remain ineffective,
leading to low quality of life and frequent use of health-
care services [3]. The contentious scholarly discourse
surrounding the application of palliative care
approaches centres on the futility debate and is often
linked to anecdotal reports, usually in the context of se-
vere anorexia nervosa [3–6, 17–20]. In these circum-
stances, there is a risk that palliative care approaches in
psychiatry may be perceived as inevitably intertwined
with ‘giving up’ and losing hope rather than as comple-
mentary to recovery-oriented models [21] for specific
cases of SPMI. However, it is important to acknowledge
that additional experimental treatment trials (e.g. low
yield, higher risk polypharmacy) can sometimes leave
patients more demoralized as they are caught in a cycle
of false hope [3]. For patients with a low probability of
a favourable treatment outcome, it is therefore import-
ant to develop a modern concept of supportive care
that does not ignore or trivialise the catastrophic effect
some mental illnesses can have. Such approaches
should focus on a psychosocial support system that
goes beyond the traditional mindset of psychiatric care.
The acceptability of certain palliative care approaches
for severe and persistent mentally ill patients whose
needs cannot be met by contemporary therapeutic in-
terventions, however, is unclear. Since psychiatrists are
the main decision makers when it comes to SPMI pa-
tients, it is crucial to initially explore the extent of ac-
ceptance of palliative care approaches in treating SPMI
patients. We therefore asked practicing physicians with
a specialist training in psychiatry (hereinafter: psychia-
trists) to evaluate the suitability of such approaches.
The main research questions concerned whether psy-
chiatrists in Switzerland considered palliative care ap-
proaches to be appropriate for SPMI in general and for
certain diagnostic groups in particular, and how they
evaluated futility in specific cases. Additionally, we were
interested in the prioritization of common treatment
goals in cases of SPMI, such as everyday functioning
and the reduction of suffering.
Methods
A quantitative cross-sectional survey was conducted in
cooperation with the Swiss Society for Psychiatry and
Psychotherapy (SSPP), in accordance with the ethical re-
view processes of the University of Zurich and the
checklist for the ethical evaluation of empirical studies.
Sample
The sample comprised all German-speaking members
of the SSPP who are practicing psychiatrists (n = 1311),
corresponding to approximately 30% of psychiatrists in
Switzerland. About 70% of psychiatrists in Switzerland
are either French- or Italian-speaking or are not SSPP
members. The rationale for sampling solely from mem-
bers of the SSPP lies in the fact that in Switzerland,
reliable contact information of physicians is only avail-
able in cooperation with relevant professional organiza-
tions such as the SSPP in which membership is not
mandatory for psychiatrists. The SSPP contacted all
participants prior to the survey to inform them of its
purpose. Data were collected in the period February–
March 2017.
Procedure
All participants received a hard copy of the survey with
an enclosed prepaid return envelope (paper-pencil
format). There was no incentive for participation.
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Participants also received a reminder postcard four
weeks later.
Survey and case vignettes
The cross-sectional survey was based on the research ques-
tions. The case vignettes drew on previously published ma-
terial [6, 22, 23] and were adapted to suit the format and
goal of the survey (see Table 1). The content of survey
items and case vignettes was revised by an advisory group
that included experts and trainees in psychiatric practice
and/or research, as well as biostatisticians. Participants were
asked to respond to 18 items on a 7-point Likert scale,
ranging from completely disagree (− 3) to completely agree
(+ 3), with a neutral mid-point (0), or from unimportant
(score: 0) to very important (6). (See Table 2 for all survey
items.) Items related to the three case vignettes (7 questions
in each) adopted the same response format. The total num-
ber of items (including case vignettes) was 42. The WHO
definition of palliative care [1] was also provided (Fig. 1).
To examine how psychiatrists would evaluate a
patient’s life expectancy, the case vignettes included a
‘surprise question’ (‘I would not be surprised if this pa-
tient died within the next 6 months’; see item S in
Table 2). In palliative care, variants of the surprise ques-
tion are often used for patient prognosis near the end of
life [24]. The survey included items concerning attitudes
to palliative sedation and physician-assisted dying for
SPMI patients (see items O, P, Q, R, X and Y in Table 2).
These are reported in a separate article.
Statistical analysis
Arithmetic means were calculated for age and work ex-
perience, and descriptive statistics (percentages) were cal-
culated for gender, as well as for all Likert scale items. In
order to facilitate readability of the results, Likert scale
items were collapsed into three categories (1, 2, 3 = agree,
0 = neutral, − 1, − 2, − 3 = disagree) in the running text.
We included 100% of participants and used
available-case analysis, i.e., we indicated the number of
missing cases separately for every question, due to the
low number of missing cases.
Results
The survey was mailed to 1311 active members of the
SSPP, and 457 surveys (34.9%) were returned of which
85% were fully completed. Of the respondents, 58.8%
were male, and 4.2% did not indicate their gender. This
gender distribution reflected the total sample of active
SSPP members (62.9% male vs. 37.1% female). Mean age
was 57.8 years (SD = .43; 95% confidence interval [CI] =
56.9, 58.6; range 35–88, missing n = 20), and mean work
Table 1 Case vignettes based on modified versions of
previously published cases (6,22,23)
Case 1: 37-year-old female with anorexia nervosa, onset at age 11
Symptoms: general muscle weakness; loss of bone density; amenorrhea; current weight 24 kg/52 lbs.; BMI 9.5 kg/m2; no recent weight gain or
stabilization; no acute danger of dying, as her body is adapted to being underweight. The patient underwent 10 previous inpatient treatments
(in both somatic and psychiatric hospitals), three of which were in specialized psychiatric institutions. Throughout the course of disease, different
intensive psychotherapies have been tried, without success. During hospitalizations, the patient underwent several artificial re-feedings, sometimes
under sedation. The patient now refuses artificial re-feeding and treatment. She states that, for years, her life has been focused exclusively on trying
to overcome her anorexia, leaving her without friends or hobbies. She suffers from the physical symptoms, including general muscle weakness and
loss in bone density, saying that she would rather die than undergo further treatment and wishes to be left in peace. She does not want to be
forced into eating anymore. Two experts have declared that the patient has decision-making capacity to refuse further treatment, with consequent
risk of dying.
Case 2: 33-year-old male with schizophrenia, onset at age 17, no significant comorbidities
Positive symptoms: auditory and visual hallucinations, persecutory delusions. Negative symptoms: apathy, social withdrawal, poverty of speech
(all rated severe). Despite long-lasting, high-dose pharmacological treatment (several atypical neuroleptics, haloperidol, clozapine and combinations
of these), as well as electro-convulsive therapy, the patient has never been free from positive or negative symptoms. Multiple psychotherapies of
various kinds have also failed to stabilize the patient or to improve his quality of life. He does not wish to continue assertive community treatment
because he feels it is too intrusive. While the positive symptoms were more dominant in the first years following initial diagnosis, he went on to
develop severe negative symptoms, as well as aggression and self-injurious behavior such as burning himself with cigarettes. The negative
symptoms and his strong functional deficits are exacerbated by chronic unemployment and inability to live independently, and the patient has no
family system. His persisting illness has left him completely isolated, with no social contacts and no hobbies or interests. Two experts have declared
that he possesses decision-making capacity in respect of his illness and its treatment.
Case 3: 40-year-old male with major depressive disorder, no significant comorbidities
Symptoms: energy loss, insomnia, fatigue, persistent suicidal ideation over 20 years, current acute and concrete suicidal intent. The patient
underwent different intensive, evidence-based, long-term psychotherapies, including specialized treatment approaches such as CBASP and IPT. His
depression was not improved either by psychotherapy alone or in combination with adequate treatment trials of antidepressants (selective
serotonin reuptake inhibitors, tricyclic antidepressants, venlafaxine, augmentation with lithium and antipsychotic medications (quetiapine and
aripiprazole)). The patient experienced significant adverse effects with several of the medications. Exhausted and as a last resort, he has decided to
undergo electro-convulsive therapy. However, maintenance electro- convulsive therapy proved equally ineffective in preventing the reappearance
of suicidal ideation; indeed, the symptoms worsened. The patient experiences severe hopelessness and states that his quality of life is very poor,
that he doesn’t want to deal with his illness anymore, and that he plans to commit suicide in the near future. Two experts have declared that he
possesses decision-making capacity regarding his illness and its treatment.
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experience was 27.7 years (SD = .44; CI = 26.8, 28.6;
missing n = 23).
Views on the general goals of care in severe and
persistent mental illness
In relation to treatment goals for SPMI, respondents most
frequently rated reduction of suffering as either important
or very important (ratings of 5 or 6 in 94.1% of responses;
CI = 91.5, 95.9%; missing n = 1). This was followed by daily
life functioning (ratings of 5 or 6 in 90.8% of responses; CI
= 87.8, 93.1%; missing n = 1), autonomy (ratings of 5 or 6
in 76.0% of responses; CI = 71.9, 79.7%; missing n = 3), and
impeding suicide (ratings of 5 or 6 in 66.1% of responses;
CI = 61.6, 70.3%; missing n = 3). Only 11.0% of respondents
rated curing the illness as an important goal (ratings of 5
or 6; CI = 8.4, 14.2%); a further 49.4% considered this
moderately important (ratings of 3 or 4; CI = 44.8, 54.1%;
missing n = 10).
Views on palliative care and its use in patients with
severe and persistent mental illness
For 45.4% of respondents, the term ‘palliative’ related dir-
ectly to end of life (ratings of 1, 2 or 3; CI = 40.8, 50.0%);
21.2% remained neutral (rating 0; CI = 17.7, 25.2%), and
33.4% did not relate the term to end of life (ratings of − 1,
− 2 or− 3; CI = 29.2, 37.9%; missing n = 5). While 78.2%
(CI = 74.1, 81.8%) of respondents said that palliative care
approaches were indicated for certain SPMI, 11.2% (CI =
86.3, 14.5%) remained neutral (missing n = 12). Similarly,
75.8% (CI = 71.6, 79.5%) of respondents thought that appli-
cation of a palliative care model was important in providing
optimal support for certain patients without a life-limiting
illness, and 13.6% (CI = 10.7, 17.0%) remained neutral
(missing n = 7). However, 94.5% (CI = 92.0, 96.2%) of all
respondents believed that SPMI could be terminal while
4.4% (CI = 2.9, 6.7%) remained neutral (missing n = 4).
When asked about the application of palliative care ap-
proaches to different mental disorders, respondents found
this most suitable for severe, chronic and therapy-refractory
schizophrenia (76.28 rating 1, 2 or 3; CI = 72.8, 80.5%; miss-
ing n = 4) and for substance disorders (75.3% rating 1, 2 or
3; CI = 71.1, 79.0%; missing n = 4). Palliative care ap-
proaches were found almost equally suitable for chronic
and therapy refractory depression (70.4.7% rating 1, 2 or 3;
CI = 66.1, 74.4%; missing n = 4); bipolar disorder (67.8%
rating 1, 2 or 3; CI = 63.3, 72.0%; missing n = 4); and
Table 2 Survey items
I: Questions on the treatment of patients with severe and persistent
mental illness (SPMI)
In the treatment of patients with severe and persistent mental illness
(SPMI), how important is:
A) curing the illness
B) reduction of suffering
C) the patient’s ability to function in daily life
D) the patient remaining autonomous in their decision making
E) impeding suicide
According to the World Health Organization (WHO), palliative care ‘is an
approach that improves the quality of life of patients and their families
facing the problem associated with life-threatening illness, through the
prevention and relief of suffering by means of early identification and
impeccable assessment and treatment of pain and other problems,
physical, psychosocial and spiritual’.
How strongly do you agree or disagree with the following.
F) For me, the term ‘palliative’ relates directly to end of life.
G) For some SPMI patients, palliative care is indicated.
H) In psychiatry, applying a palliative care model is important
in providing optimal support for certain patients without a
life-limiting medical illness.
I) In severe, chronic and therapy-refractory anorexia nervosa, a
palliative approach would be suitable.
J) In severe, chronic and therapy-refractory schizophrenia, a
palliative approach would be suitable.
K) In severe, chronic and therapy-refractory depression, a palliative
approach would be suitable.
L) In severe, chronic and therapy-refractory bipolar disorder, a
palliative approach would be suitable.
M) In severe, chronic and therapy-refractory substance disorder,
a palliative approach would be suitable.
How strongly do you agree or disagree with the following.
N) SPMI can be a terminal illness.
O) Sedation for the reduction of unbearable refractory
psychological symptoms is justifiable in certain cases of SPMI.
P) I would generally be willing to perform sedation as mentioned
above in ‘O’.
Q) I generally advocate access to assisted suicide for patients
with SPMI.
R) If physician-assisted suicide was legally permitted for SPMI, I
would support my patients in seeking this intervention as the
physician of record or by referring them to another physician.
II: Questions about the three case vignettesa
Please evaluate the case vignettes as below.
S) I would not be surprised if this patient died within the
next 6 months.
T) For this patient, further interventions to cure the anorexia would
most likely be futile.
U) In this case, I would be comfortable with a reduction of life
expectancy in order to increase or maintain quality of life if
consistent with the patient’s goals.
V) In this case, I would accept a temporary decrease in quality of
life due to coercive measures.
W) In this case, I would not proceed against the patient’s wishes.
Table 2 Survey items (Continued)
X) In this case, sedation to reduce an unbearable refractory
symptom is reasonable.
Y) If physician-assisted suicide was legally permitted, I would
support this patient if this was her explicit and enduring wish,
referring her to appropriate care.
aNote: Questions S–Y applied to all three case vignettes in Table 1
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anorexia nervosa (67.7% rating 1, 2 or 3; CI = 63.3, 71.9%;
missing n = 5) (Fig. 1).
Responses to vignettes
Anorexia nervosa
A majority of respondents indicated that they would not
be surprised if the anorexia nervosa patient died within
the next 6 months (87.2% rating 1, 2 or 3, where 3 desig-
nated strongly agree; CI = 83.8, 90.0%; missing n = 3).
(For all case vignettes, see Table 1). Most respondents
agreed that further interventions to cure the anorexia
nervosa would most likely be futile (73.1% rating 1, 2 or
3; CI = 68.8, 77.0%; missing n = 4), and 82.3% (CI = 78.5,
85.5%) indicated that they would be comfortable with a
Fig. 1 Psychiatrists’ attitudes to palliative care and severe and persistent mental illness
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reduction in life expectancy in order to increase or
maintain quality of life in such cases (missing n = 5).
Schizophrenia
While almost half of respondents indicated that they
would not be surprised if the patient diagnosed with
schizophrenia died within the next 6 months (45.1%; CI
= 40.9, 49.3%), more than a quarter remained neutral
(26.9% rating 0; CI = 23.0, 31.2%) with regard to this
item (missing n = 7). A majority agreed that further in-
terventions to cure the schizophrenia would most likely
be futile (64.8% rating either 1, 2 or 3; CI = 60.2, 69.0%;
missing n = 9), and 72.8% (CI = 68.5, 76.7%) indicated
that they would be comfortable with a reduction of life
expectancy in order to increase or maintain quality of
life (missing n = 9).
Major depressive disorder
A sizeable majority of respondents indicated that they
would not be surprised if the patient diagnosed with
major depressive disorder died within the next 6 months
(83.8% rating 1, 2 or 3, where 3 designated strongly
agree; CI = 80.1, 86.9%; missing n = 7). Slightly more than
half agreed that further interventions to cure the depres-
sion would most likely be futile (53.6% rating 1, 2 or 3;
CI = 48.9, 58.1%; missing n = 7), and 69.3% (CI = 64.9,
73.4%) indicated that they would be comfortable with a
reduction of life expectancy in order to increase or
maintain quality of life (missing n = 7) (Fig. 2).
Discussion
Acceptability of palliative care approaches in mental
health care
In this survey of psychiatrists in Switzerland, almost all
respondents believed that SPMI can be a terminal ill-
ness, and that curing the illness has a lower priority than
other care goals such as reduction of suffering and func-
tioning in daily life. These findings align with previous
conceptual work which suggested that some existing
clinical approaches in contemporary psychiatry can be
considered palliative because their primary aim is not re-
mission or illness modification [2]. The broad consensus
about the fatality of certain severe cases of mental illness
is particularly noteworthy given the ‘loud silence’ with
regard to death and dying (other than suicide and its
prevention) in mental healthcare. Premature mortality is
a neglected aspect in mental health care. Accepting it as
an unchangeable outcome [25], or completely ignoring it
in the development of new treatment approaches is
harmful to the most vulnerable of all patients. It is
hoped that by acknowledging that this group of patients
is at greater risk of dying [26], additional resources can
be freed up in order to improve the care of these pa-
tients. In summary, our findings suggest widespread
agreement among the respondents on the suitability of
general palliative care approaches in treating SPMI. One
issue raised by several participants in the comment sec-
tion of the survey was the concern expressed by some
experts about the possible impact of characterising men-
tal health treatments as ‘palliative’, which might be seen
to imply ‘giving up’ on patients [17–19, 27]. Indeed, the
term ‘palliative’ may not be ideal, given its associations
with terminal illness [3]; almost half of our respondents
felt that it was closely related to end-of-life care, indicat-
ing a heterogeneous understanding of palliative care,
even among health care professionals.
It is important to stress that the use of palliative care
in psychiatry (as in other areas of healthcare) does not
exclude other treatment approaches. The features of pal-
liative care approaches, such as the ongoing alliance with
patients and their relatives [3], exquisite symptom man-
agement and pursuit of patient and family goals for care
and for life in general are, for example, compatible and
consistent with the principles of the recovery model [4].
In this sense, palliative care approaches may offer psy-
chiatrists additional tools in the care of SPMI, particu-
larly where patient needs and goals cannot be met by
current psychiatric interventions. However, the discom-
fort about introducing approaches that used to be re-
served for a terminally ill population in psychiatric
treatment of SPMI patients has to be taken seriously and
has to be critically accompanied scientifically. Specific-
ally, it has to be evaluated whether using a less loaded
term such as supportive care can improve acceptance of
the concept [28].
With regard to the case vignettes, participants prioritized
quality of life over patients’ remaining life expectancy, and
in all three cases, the great majority doubted that further
interventions to cure the illness would be successful. This
finding aligns with conceptual questions concerning the
importance of curing SPMI as compared to other goals of
care such as reduction of suffering and functioning in daily
life. The overall consensus that curative approaches would
most likely be futile in certain specific cases of SPMI con-
firms the need to further explore the concept of medical
futility in psychiatry. Objections to the applicability of this
concept in cases of chronic psychiatric illness are multifa-
ceted [17, 19]. However, even if one accepts these argu-
ments and concludes that the concept is not relevant in
the context of mental illness, the question remains of how
best to deal with the reality of unremitting or progressively
declining mental illness. In summary, while it could be
argued that the recovery-based model and the harm reduc-
tion approaches already seek to minimize symptoms in
acute and maintenance phases, we believe that the consid-
erations above have implications that go beyond of what is
currently available, especially with regard to futility and last
resort therapeutic interventions.
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Lack of specificity of the conceptual framework
It seems clear that the concepts and framework underpin-
ning palliative care approaches in a psychiatric context
require further elucidation, including the issue of how
specific palliative care interventions might be imple-
mented. In particular, advocates need to elaborate how
palliative care might be applied to psychiatric illness, in-
cluding the prevention and relief of suffering, prevention
of futile and burdensome interventions and improvement
of quality of life. Any such investigation of the feasibility
of specific palliative care interventions lies beyond the
scope of the present study. It should also be noted that
the WHO definition of palliative care provided in the sur-
vey (see Table 2) was described by several respondents as
vague and applicable to many (if not all) forms of psychi-
atric treatment. The high variability in the results might
be one indication for a lack of consensus on what pallia-
tive care approaches in this context would comprise. This
aspect hast to be taken into consideration when interpret-
ing the data, and it will be crucial to develop a minimum
consensus regarding the definition of palliative care
approaches in order to further develop this area.
Fig. 2 Summary of psychiatrists’ attitudes to life expectancy, futility and quality of life with regard to the three clinical case vignettes
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Strengths and limitations
The present study has a number of strengths. Previously,
palliative care approaches in psychiatry have been dis-
cussed mainly at a conceptual level by ethicists and
experienced clinicians. We are aware of only one other
study that tackles the topic empirically through qualita-
tive interviews [29], focusing on commonalities between
contemporary mental healthcare and palliative care phil-
osophies. It is argued here that the similarities between
mental health services and palliative care principles can
serve as a foundation for integrating these approaches
into mental health services.
The present study is the first survey to use quantitative
methods to explore mental health professionals’ attitudes to
the treatment of SPMI patients in general, and to the use of
certain palliative care approaches in particular. In light of
the controversy surrounding that discussion, this insight is
an important first step towards establishing the relevance of
the palliative care concept in mental health care.
The study also has several limitations. Although Likert
scale items are an accepted means of conducting quanti-
tative surveys, the options offered can only approximate
complex multidimensional concepts.
In assembling the study’s advisory group, our rationale
was to include on the one hand persons who were able to
advise us with relevant knowledge on the research ques-
tions and the content of the survey including experts and
trainees in psychiatry, psychology, and palliative care, and
on the other hand, professionals with regard to survey de-
sign issues and statistics (psychologist and biostatistician).
However, it’s a limitation that no other stakeholders such
as patients, family, or policy makers have been part of the
advisory board. The present evidence depends on only
457 completed surveys. This corresponds to about 10% of
psychiatrists in Switzerland. In addition, the sample was
confined to German-speaking members of the SSPP and
may not be representative for all psychiatrists practicing in
Switzerland. Furthermore, the results are not generalizable
to other mental health care professionals who might be in-
volved in the care of patients with SPMI such as nurses
and psychologists. The nonresponse rate raises the possi-
bility of response bias. It might be possible that psychia-
trists with particular pre-existing normative beliefs were
disproportionally represented. However, the demographics
correspond to the total of all psychiatrists in Switzerland
and the results have a high variability, suggesting a minor
impact of the response bias on our data. Lastly, it is im-
portant to note that an available case analysis was used in
order to minimize loss of data.
Lastly, it is important to note that an available case
analysis was used in order to minimize loss of data but
that the known disadvantages of this, e.g., that the stand-
ard of errors computed by most software packages uses
the average sample size across analyses, do not apply for
our study because we haven’t used inferential statistics
and used available cases for SD’s and confidence inter-
vals as well.
Implications for clinical practice
The present findings indicate that many psychiatrists—at
least in Switzerland—consider that palliative care
approaches may be suitable for certain cases of SPMI. For
clinical practice, this means that palliative care represents a
possible option in the treatment of SPMI patients and the
psychiatric profession’s readiness to introduce some of these
tools to clinical care. To explore this option, the psychiatric
profession must design a framework for use and a common
language for the field, and must subsequently create an evi-
dence base capturing the impact on clinical outcomes for
SPMI patients. Most importantly, palliative approaches must
be seen as an addition to rather than a replacement for
other novel and promising person-centred approaches, such
as the recovery movement [4, 21]. It remains open whether
the term ‘palliative’ will have majority appeal or whether pal-
liative care principles will merely inform a modern concept
of psychosocial support for SPMI patients.
Future research
While this study offers some insight into how the sur-
veyed psychiatrists appraise the implementation of pal-
liative care approaches in mental healthcare, it is mainly
to be interpreted as a starting point of the discussion. It
remains unclear how the concept might be assessed by
affected patients, and the specifics of palliative care in-
terventions remain to be defined. The next step will be
to develop a framework for differential indication—that
is, to identify which patients would qualify for or benefit
from a palliative care approach. It will be crucial for fur-
ther development to adequately involve patients and put
their needs first.
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